Evidence map›Paper›PMID 34634176›Full record

ArticleHIV medicine2022

Alcohol, smoking, recreational drug use and association with virological outcomes among people living with HIV: cross-sectional and longitudinal analyses.

Timothy P W Jones, Fiona C Lampe, Alejandro Arenas-Pinto, Colette Smith, Jeff McDonnell, Lewis Haddow, Margaret Johnson, Elaney Yousef, Monica Lascar, Anna Maria Geretti and 5 more

Open access · hybridAbstract read
In one paragraph

Article in HIV medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. HIV-associated lung disease.Nature reviews. Disease primers · 2023
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Timothy P W JonesRoyal Free Hospital Foundation Trust, London, UK.ORCID 0000-0001-6147-6748
Fiona C LampeResearch Department of Infection & Population, University College London, London, UK.
Alejandro Arenas-PintoResearch Department of Infection & Population, University College London, London, UK.
Colette SmithResearch Department of Infection & Population, University College London, London, UK.ORCID 0000-0003-2847-3355
Jeff McDonnellResearch Department of Infection & Population, University College London, London, UK.
Lewis HaddowResearch Department of Infection & Population, University College London, London, UK.
Margaret JohnsonRoyal Free Hospital Foundation Trust, London, UK.
Elaney YousefBrighton and Sussex University Hospitals, Brighton, UK.
Monica LascarBarts Health NHS Trust, London, UK.
Anna Maria GerettiInstitute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Lorraine SherrResearch Department of Infection & Population, University College London, London, UK.
Simon CollinsHIV i-Base, London, UK.
Andrew N PhillipsResearch Department of Infection & Population, University College London, London, UK.ORCID 0000-0003-2384-4807
Alison J RodgerResearch Department of Infection & Population, University College London, London, UK.ORCID 0000-0001-8817-4651
ASTRA Study Group
University of London · GBRoyal Free London NHS Foundation Trust · GBBarts Health NHS Trust · GBBritish HIV Association · GBUniversity of Liverpool · GB

Funding

Department of Health RP-PG-0608-10142
6 · The paper itself

Abstract

objectivesThere is increasing evidence to suggest that people living with HIV (PLWH) have significant morbidity from alcohol, recreational drug use and cigarette smoking. Our aim was to report associations of these factors with antiretroviral therapy (ART) non-adherence, viral non-suppression and subsequent viral rebound in PLWH.

methodsThe Antiretroviral Sexual Transmission Risk and Attitudes (ASTRA) study recruited PLWH attending eight outpatient clinics in England between February 2011 and December 2012. Data included self-reported excessive drinking (estimated consumption of > 20 units of alcohol/week), alcohol dependency (CAGE score ≥ 2 with current alcohol consumption), recreational drug use (including injection drug use in the past 3 months), and smoking status. Among participants established on ART, cross-sectional associations with ART non-adherence [missing ≥2 consecutive days of ART on ≥2 occasions in the past three months] and viral-non suppression [viral load (VL) > 50 copies/mL] were assessed using logistic regression. In participants from one centre, longitudinal associations with subsequent viral rebound (first VL > 200 copies/mL) in those on ART with VL ≤ 50 copies/mL at baseline were assessed using Cox regression during a 7-year follow-up.

resultsAmong 3258 PLWH, 2248 (69.0%) were men who have sex with men, 373 (11.4%) were heterosexual men, and 637 (19.6%) were women. A CAGE score ≥ 2 was found in 568 (17.6%) participants, 325 (10.1%) drank > 20 units/week, 1011 (31.5%) currently smoked, 1242 (38.1%) used recreational drugs and 74 (2.3%) reported injection drug use. In each case, prevalence was much more common among men than among women. Among 2459 people on ART who started at least 6 months previously, a CAGE score ≥ 2, drinking > 20 units per week, current smoking, injection and non-injection drug use were all associated with ART non-adherence. After adjusting for demographic and socioeconomic factors, CAGE score ≥ 2 [adjusted odds ratio (aOR) = 1.52, 95% confidence interval (CI): 1.09-2.13], current smoking (aOR = 1.58, 95% CI: 1.10-2.17) and injection drug use (aOR = 2.11, 95% CI: 1.00-4.47) were associated with viral non-suppression. During follow-up of a subset of 592 people virally suppressed at recruitment, a CAGE score ≥ 2 [adjusted hazard ratio (aHR) = 1.66, 95% CI: 1.03-2.74], use of 3 or more non-injection drugs (aHR = 1.82, 95% CI: 1.12-3.57) and injection drug use (aHR = 2.73, 95% CI: 1.08-6.89) were associated with viral rebound.

conclusionsScreening and treatment for alcohol, cigarette and drug use should be integrated into HIV outpatient clinics, while clinicians should be alert to the potential for poorer virological outcomes.

Indexed as

Anti-HIV AgentsHIV InfectionsSexual and Gender MinoritiesCross-Sectional StudiesFemaleHomosexuality, MaleHumansMaleMedication AdherenceRecreational Drug UseSmokingViral LoadAnti-HIV Agentsadherencealcohol dependencerecreational drugssmokingviral non-suppression

Identifiers

PMID34634176
PMCPMC9293433
OpenAlexW3207713279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.